What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Gene
His main research concerns Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin.
In his study, Weight loss is strongly linked to Surgery, which falls under the umbrella field of Internal medicine.
His Endocrinology study integrates concerns from other disciplines, such as Strength training and Senescence.
His research investigates the connection between Diabetes mellitus and topics such as Randomized controlled trial that intersect with problems in Gerontology, Disease, Clinical trial, Hypoglycemia and Insulin glargine.
Richard E. Pratley mostly deals with Liraglutide in his studies of Type 2 diabetes.
His Insulin research is multidisciplinary, relying on both Rate ratio, Bedtime and Intensive care medicine.
His most cited work include:
- Leptin levels in human and rodent : Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects (3260 citations)
- Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. (3096 citations)
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. (1526 citations)
What are the main themes of his work throughout his whole career to date?
Richard E. Pratley mostly deals with Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Insulin.
When carried out as part of a general Internal medicine research project, his work on Weight loss is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
Endocrinology is represented through his Insulin resistance, Obesity, Glucose tolerance test, Adipose tissue and Leptin research.
His work deals with themes such as Metformin, Pharmacology and Intensive care medicine, which intersect with Type 2 diabetes.
His Diabetes mellitus research is multidisciplinary, incorporating perspectives in Tolerability, Randomized controlled trial and Clinical trial.
Insulin is often connected to Pima indians in his work.
He most often published in these fields:
- Internal medicine (75.71%)
- Endocrinology (57.49%)
- Type 2 diabetes (36.44%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (75.71%)
- Type 2 diabetes (36.44%)
- Semaglutide (5.67%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Type 2 diabetes, Semaglutide, Type 1 diabetes and Liraglutide.
His Internal medicine research integrates issues from Basal insulin and Endocrinology.
His Endocrinology study often links to related topics such as Meal.
The various areas that Richard E. Pratley examines in his Type 2 diabetes study include Severe hypoglycemia, Clinical trial, Disease and Intensive care medicine.
His Liraglutide research also works with subjects such as
- Glucagon-like peptide-1 that connect with fields like Diabetes type ii, Body mass index and Post hoc,
- Blood pressure that connect with fields like Cardiology and Cohort,
- Receptor which intersects with area such as Adipocyte, Pharmacology, Adipose tissue and Metformin,
- Body weight which is related to area like Ldl cholesterol, INSULIN USE and Standard care,
- Mace which is related to area like Sensitivity analyses.
His work on Diabetic ketoacidosis as part of his general Insulin study is frequently connected to Interleukin 21, thereby bridging the divide between different branches of science.
Between 2017 and 2021, his most popular works were:
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial (190 citations)
- DESIGN AND BASELINE CHARACTERISTICS OF THE EVALUATION OF ERTUGLIFOZIN EFFICACY AND SAFETY CARDIOVASCULAR OUTCOMES TRIAL (VERTIS-CV) (40 citations)
- Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts (10 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Gene
The scientist’s investigation covers issues in Internal medicine, Type 2 diabetes, Liraglutide, Semaglutide and Type 1 diabetes.
His work on Glycemic, Baseline characteristics and Cardiovascular outcomes as part of general Internal medicine study is frequently linked to Ertugliflozin and Event, bridging the gap between disciplines.
His study looks at the intersection of Type 2 diabetes and topics like Randomized controlled trial with Weight loss, Dulaglutide, Clinical trial and Cohort.
His Liraglutide study deals with the bigger picture of Endocrinology.
As part of his studies on Endocrinology, Richard E. Pratley often connects relevant subjects like Post hoc.
His work investigates the relationship between Insulin and topics such as Standard care that intersect with problems in Severe hypoglycemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
